Posts Tagged: Cell & Tissue Engineering
May 26, 2021 | An innovative biomaterial discovery by researchers at the University of Toronto in collaboration with Ripple Therapeutics Inc., has established a method that yields better control over drug release profiles in implants and has the potential to disrupt the classical drug delivery market.
January 6, 2021 | Supported by U of T's Medicine by Design initiative, a multidisciplinary team led by University Professor Molly Shoichet (ChemE, BME, Donnely) plans to use retinal stem cells to restore vision.
November 4, 2020 | Paul Santerre, a professor in the Faculty of Dentistry and the Institute of Biomedical Engineering, says the extent of progress on diabetes and insulin will partly depend on how well research breakthroughs from scholars like Brubaker can be married with efforts at commercialization and innovation.
August 24, 2020 | A team of researchers from U of T Engineering and the University of Michigan have redesigned and enhanced a natural enzyme that shows promise in promoting the regrowth of nerve tissue following injury.
August 13, 2020 | U of T Engineering researchers have developed a new method of injecting healthy cells into damaged eyes. The technique could point the way toward new treatments with the potential to reverse forms of vision loss that are currently incurable.
May 1, 2020 | U of T researchers develop ‘piggyback’ vehicle to escape the endosomal trap and deliver RNA therapeutics
April 08, 2020 | Milica Radisic (ChemE, IBBME) is working with Axel Guenther and Edmond Young (both MIE) to create tiny models of the nose, mouth, eyes and lungs to better understand how COVID-19 infects organs
February 4, 2020 | A new handheld 3D printer can deposit sheets of skin to cover large burn wounds – and its “bio ink” can accelerate the healing process.
January 17, 2020 | Researchers from IBBME developed a method to improve the transplantation success rate of artificial islets.
October 25, 2019 | Interface Biologics's (IBI) antithrombogenic additive have been used in a new line of FDA-approved "breakthrough" dialysis products made by IBI's partner, Fresenius Medical Care.
Showing 41 - 50 of 89 results